MedPath

Exhaled breath analysis to diagnose acute lung injury.

Conditions
ARDS, non-invasive diagnostic tests, early detection, octaneDutch: ARDS, niet-invasieve diagnostische methoden, vroege detectie, octane
Registration Number
NL-OMON27817
Lead Sponsor
Amsterdam UMC, locatie AMC.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
500
Inclusion Criteria

Intubated and mechanically ventilated for less than 48 hours.

Exclusion Criteria

•Patient is expected to be deceased within 24 hours.

•Exhaled breath collection deemed inappropriate by the attending physicians.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Exhaled breath concentration of octane, measure by compact gas-chromatography.
Secondary Outcome Measures
NameTimeMethod
•Volatile organic compounds in exhaled breath measured by gas-chromatography and mass-spectrometry. <br /><br>•Protein patterns in fluid from the heat-moist exchanger. <br /><br>•Non-invasive imaging techniques: <br /><br>oLung ultrasound <br /><br>oElectrical impedance tomography. <br /><br>•Lung injury prediction score.<br /><br>•ARDS as defined by the Berlin Definition<br /><br>•Therapeutic response in ARDS patients<br /><br>•ARDS phenotypes defined by clinical characteristics and by a biomarker profile of plasma biomarkers
© Copyright 2025. All Rights Reserved by MedPath